Showing results (41-50 of 64) with videos related to
Sort By:
Pageof 7
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|July 31, 2008
Efficacy of bazedoxifene in reducing new vertebral fracture risk in postmenopausal women with osteoporosis: results from a 3-year, randomized, placebo-, and active-controlled clinical trialStuart L Silverman, Claus Christiansen, Harry K Genant, et al.Maturitas|July 23, 2013
Assessment of the safety of long-term bazedoxifene treatment on the reproductive tract in postmenopausal women with osteoporosis: results of a 7-year, randomized, placebo-controlled, phase 3 studySantiago Palacios, Tobie J de Villiers, Fiorenzo De Cicco Nardone, et al.Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|August 6, 2000
Prevention of bone loss with risedronate in glucocorticoid-treated rheumatoid arthritis patientsR Eastell, J P Devogelaer, N F Peel, et al.The Journal of Clinical Endocrinology and Metabolism|May 10, 2001
Effect of combined risedronate and hormone replacement therapies on bone mineral density in postmenopausal womenS T Harris, E F Eriksen, M Davidson, et al.Bone|April 29, 2015
The effects of bazedoxifene on bone structural strength evaluated by hip structure analysisThomas J Beck, Thomas Fuerst, Kenneth W Gaither, et al.Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|June 11, 2010
Safety and tolerability of bazedoxifene in postmenopausal women with osteoporosis: results of a 5-year, randomized, placebo-controlled phase 3 trialT J de Villiers, A A Chines, S Palacios, et al.Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|September 24, 2018
The risk of subsequent osteoporotic fractures is decreased in subjects experiencing fracture while on denosumab: results from the FREEDOM and FREEDOM Extension studiesD L Kendler, A Chines, M L Brandi, et al.Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|November 29, 2019
Efficacy and safety of denosumab vs. bisphosphonates in postmenopausal women previously treated with oral bisphosphonatesP D Miller, N Pannacciulli, J Malouf-Sierra, et al.Journal of Bone and Mineral Metabolism|April 10, 2014
Bridging analysis of the efficacy and safety of bazedoxifene in Japanese and global populations of postmenopausal women with osteoporosisAkira Itabashi, Kousei Yoh, Arkadi A Chines, et al.Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|July 23, 2011
Sustained efficacy and safety of bazedoxifene in preventing fractures in postmenopausal women with osteoporosis: results of a 5-year, randomized, placebo-controlled studyS L Silverman, A A Chines, D L Kendler, et al.Pageof 7